resveratrol has been researched along with tanespimycin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, PK; Chatterjee, M; Ganguly, S; Mustafi, SB; Raha, S | 1 |
1 other study(ies) available for resveratrol and tanespimycin
| Article | Year |
|---|---|
Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Blotting, Western; Caspase 3; Cell Nucleus; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; K562 Cells; Lactams, Macrocyclic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Promoter Regions, Genetic; Resting Phase, Cell Cycle; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Stilbenes; Transcription Factors | 2008 |